Medicenna Announces Completion of Enrolment in MDNA55 Phase 2b Recurrent Glioblastoma Clinical Study
Medicenna Therapeutics Corp. ("Medicenna" or...
Read MoreMedicenna Therapeutics Corp. ("Medicenna" or...
Read MoreThe International Pharmaceutical Federation (FIP)...
Read MoreCloudnine Group of Hospitals said...
Read MoreOn this World Malaria Day,...
Read MoreChandigarh, 19th April, 2019 :...
Read MoreThe US Food and Drug...
Read MoreElpiscience BioPharma and Bio-Techne Corporation...
Read MoreOfficials with the FDA have...
Read MoreUnion Minister of Health and...
Read More